Table 4.
Summary: Open questions in the field.
Research question | Figure | |
---|---|---|
1 | Does regional vulnerability to normal ageing determine region-specific susceptibility in neurodegenerative disease? | 1 |
2 | Do mechanisms of ageing at the nervous system tissue, cellular and molecular level determine regional vulnerability to both normal ageing and neurodegenerative disease? | 2 |
3 | Can differential ageing conceptually extend across scales, from the individual to subcellular level? | 3 |
4 | Are the initial sites affected by neurodegenerative pathology also those that are most prone to ageing? | – |
5 | Can the concept of regional susceptibility to ageing be extended across other age-related diseases, such as cardiovascular disease? | – |
6 | Is it experimentally tractable to directly compare the ageing status of single cells, cellular subregions, or individual organelles within cells? | – |
7 | How can an understanding of region-specific vulnerability to ageing and disease be used to guide therapeutic advance e.g. ASO delivery, cellular implantation? | – |